Compound rhizoma coptidis medicine and application thereof
A technology of Coptis chinensis and medicaments, applied in the direction of suppository delivery, drug combination, drug delivery, etc., can solve the problems of less obvious curative effect, high treatment cost, low cure rate, etc., and achieve good curative effect, strong drug permeability and stable drug effect Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Embodiment one: the preparation of compound coptis medicament
[0033] The invention provides a compound coptis medicament. The compound coptis medicament comprises 20%-40% of main drug and 60%-80% of matrix by weight percentage.
[0034] In the present invention, the base may be a suppository base or an ointment base.
[0035] Concretely, the main drug in the present invention includes 14-16% of berberine powder, 3-5% of erythromycin powder, 26-29% of metronidazole powder, 15-18% of Phellodendron phellodendron powder, and Scutellaria baicalensis powder by weight percentage. 17-19% parts, borneol 5-7%, dyclonine powder 2-4%, lidocaine powder 10-13%, ethylparaben 0.3-0.5%.
[0036] Specifically, the suppository base of the present invention is a mixed fatty acid glyceride.
[0037] Specifically, the ointment base of the present invention includes, by weight, 6-9 parts of petrolatum, 4-7 parts of lanolin, 1-2 parts of beeswax, and 1-2 parts of yellow wax.
Embodiment 2
[0038] Embodiment two: the preparation of compound coptis chinensis medicament
[0039] The invention provides a compound coptis medicament. The compound coptis medicament comprises 20% of main drug and 80% of matrix by weight percentage.
[0040] In the present invention, the base may be a suppository base or an ointment base.
[0041] Preferably, the main drug in the present invention includes 14.5% of berberine powder, 4% of erythromycin powder, 27% of metronidazole powder, 16% of Phellodendron Phellodendron powder, 17.5% of Scutellaria baicalensis powder, 6% of borneol, Dacronine powder 3%, lidocaine powder 11.6%, ethyl paraben 0.4%.
[0042] Specifically, the suppository base of the present invention is a mixed fatty acid glyceride.
[0043] Preferably, the ointment base in the present invention comprises 7 parts of vaseline, 5 parts of lanolin, 1 part of beeswax and 1 part of yellow wax in parts by weight.
Embodiment 3
[0044] Embodiment three: the preparation of compound coptis chinensis medicament
[0045] The invention provides a preparation method of compound Coptis chinensis medicament, the specific method steps are as follows:
[0046] (1) The main drug raw materials berberine powder, erythromycin powder, metronidazole powder, cork powder, scutellaria baicalensis powder, borneol, dyclonine powder, lidocaine powder, ethyl paraben, selected to remove impurities Grind the fine powder separately, filter through a No. 6 medicine sieve, and mix in proportion;
[0047] (2) Stir the mixed main drug raw material powder prepared in step (1) with the mixed fatty acid glyceride melted to 60°C, pour it into a suppository mold, open the mold after cooling, take out the prepared suppository and pack it into a box, ready to use;
[0048] (3) Heat medical vaseline, lanolin, beeswax, and yellow wax to form a paste, then add the mixed main drug raw material powder prepared in step (2) into the ointment ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com